Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Hypersensitivity Reaction

  Free Subscription


Articles published in J Dermatol

Retrieve available abstracts of 66 articles:
HTML format



Single Articles


    November 2022
  1. SAEKI H, Akiyama M, Abe M, Igarashi A, et al
    English version of Japanese guidance for the use of oral Janus kinase (JAK) inhibitors in the treatments of atopic dermatitis.
    J Dermatol. 2022 Nov 22. doi: 10.1111/1346-8138.16635.
    PubMed     Abstract available


  2. MIYAKE R, Iwamoto K, Sakai N, Matsunae K, et al
    Uptake of Staphylococcus aureus by keratinocytes is reduced by interferon-fibronectin pathway and filaggrin expression.
    J Dermatol. 2022;49:1148-1157.
    PubMed     Abstract available


  3. CHEN H, Zhang G, Zhang P, Long H, et al
    Case of borderline leprosy presenting with urticaria-like eruptions and limbs swelling: A lesson to be learned for dermatologists.
    J Dermatol. 2022;49:e409-e410.
    PubMed    


    October 2022
  4. MIYAJI Y, Yamamoto-Hanada K, Fukuie T, Narita M, et al
    Risk factors of admission in school children with severe atopic dermatitis.
    J Dermatol. 2022 Oct 18. doi: 10.1111/1346-8138.16612.
    PubMed     Abstract available


    September 2022
  5. LEE ES, Kiuchi Y, Inomata N, Sueki H, et al
    Increased expression of human herpes virus 6 receptor CD134/OX40 in skin lesions of patients with drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms.
    J Dermatol. 2022 Sep 19. doi: 10.1111/1346-8138.16575.
    PubMed     Abstract available


  6. TANAKA A, Niimi N, Takahashi M, Takahashi H, et al
    Prevalence of skin diseases and prognosis of atopic dermatitis in primary school children in populated areas of Japan from 2010 to 2019: The Asa Study in Hiroshima, Japan.
    J Dermatol. 2022 Sep 19. doi: 10.1111/1346-8138.16577.
    PubMed     Abstract available


  7. HATTORI N, Koike Y, Murota H
    Skin microbiome analysis in a case of atopic dermatitis induced by an interleukin 17 inhibitor used to treat psoriasis.
    J Dermatol. 2022 Sep 19. doi: 10.1111/1346-8138.16586.
    PubMed    


  8. FENG S, Song G, Liu L, Liu W, et al
    Allergen-specific immunotherapy induces monocyte-derived dendritic cells but attenuates their maturation and cytokine production in the lesional skin of an atopic dermatitis mouse model.
    J Dermatol. 2022 Sep 19. doi: 10.1111/1346-8138.16582.
    PubMed     Abstract available


    August 2022
  9. SAEKI H, Ohya Y, Furuta J, Arakawa H, et al
    English Version of Clinical Practice Guidelines for the Management of Atopic Dermatitis 2021.
    J Dermatol. 2022 Aug 22. doi: 10.1111/1346-8138.16527.
    PubMed     Abstract available


  10. HAGINO T, Saeki H, Kanda N
    The efficacy and safety of upadacitinib treatment for moderate to severe atopic dermatitis in real-world practice in Japan.
    J Dermatol. 2022 Aug 19. doi: 10.1111/1346-8138.16549.
    PubMed     Abstract available


  11. YAMASHITA A, Fukui T, Akasaka E, Nakajima K, et al
    A mild case of acute generalized exanthematous pustulosis caused by gemcitabine.
    J Dermatol. 2022;49:e261-e263.
    PubMed    


    July 2022
  12. KAWAKAMI T, Yokoyama K, Ikeda T, Nishibata Y, et al
    Presence of neutrophil extracellular traps in superficial venous thrombosis of Behcet's disease.
    J Dermatol. 2022;49:741-745.
    PubMed     Abstract available


  13. KITAO R, Oda Y, Washio K, Tai Y, et al
    Lower efficacy of omalizumab in older adults with chronic spontaneous urticaria.
    J Dermatol. 2022;49:729-731.
    PubMed     Abstract available


    June 2022
  14. KATOH N, Saeki H, Kataoka Y, Etoh T, et al
    Evaluation of standard treatments for managing adult Japanese patients with inadequately controlled moderate-to-severe atopic dermatitis: Two-year data from the ADDRESS-J disease registry.
    J Dermatol. 2022 Jun 17. doi: 10.1111/1346-8138.16485.
    PubMed     Abstract available


  15. CHI MH, Chung WH, Hui RC, Chen CB, et al
    Clinical features and outcomes in children with Stevens-Johnson syndrome and toxic epidermal necrolysis.
    J Dermatol. 2022 Jun 17. doi: 10.1111/1346-8138.16476.
    PubMed     Abstract available


  16. CHIANG CP, Hung CT, Chen YH, Chen CY, et al
    Stevens-Johnson syndrome and toxic epidermal necrolysis associated with increased risk of developing psychiatric disorders: A retrospective population-based cohort study in Taiwan.
    J Dermatol. 2022 Jun 10. doi: 10.1111/1346-8138.16487.
    PubMed     Abstract available


  17. YANAGIDA N, Takahagi S, Aoyama Y, Tanaka A, et al
    Anhidrosis accompanied by cholinergic urticaria-like rash and dermal pain in a patient with Sjogren's syndrome.
    J Dermatol. 2022;49:666-670.
    PubMed     Abstract available


    May 2022
  18. SALAVA A, Salo V, Remitz A
    Keratosis pilaris and filaggrin loss-of-function mutations in patients with atopic dermatitis - Results of a Finnish cross-sectional study.
    J Dermatol. 2022 May 26. doi: 10.1111/1346-8138.16477.
    PubMed     Abstract available


  19. MATSUDATE Y
    Case of allergic contact dermatitis due to nickel contained in stainless steel skull pins.
    J Dermatol. 2022 May 3. doi: 10.1111/1346-8138.16421.
    PubMed    


  20. TAKAMIYAGI S, Iriki H, Asahina Y, Furuichi Y, et al
    Severe graft-versus-host disease-like enterocolitis accompanied with cytomegalovirus-reactivation in drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms.
    J Dermatol. 2022 May 2. doi: 10.1111/1346-8138.16415.
    PubMed     Abstract available


  21. HASHIZUME H, Ajima S, Ishikawa Y
    Immunoglobulin A vasculitis post-severe acute respiratory syndrome coronavirus 2 vaccination and review of reported cases.
    J Dermatol. 2022;49:560-563.
    PubMed     Abstract available


    April 2022
  22. KIMURA H, Umemori Y, Yuki D
    Anaphylactic shock-like symptoms due to niacin overdose: A case report.
    J Dermatol. 2022 Apr 27. doi: 10.1111/1346-8138.16410.
    PubMed    


  23. BOMZE D, Sprecher E, Geller S
    Severe cutaneous adverse reactions associated with systemic ivermectin: A pharmacovigilance analysis.
    J Dermatol. 2022 Apr 27. doi: 10.1111/1346-8138.16398.
    PubMed     Abstract available


  24. YU R, Chen S, Pan Y, Ma C, et al
    Combined use of cyclosporine in the treatment of Stevens-Johnson syndrome/toxic epidermal necrolysis.
    J Dermatol. 2022 Apr 19. doi: 10.1111/1346-8138.16369.
    PubMed     Abstract available


  25. KURIHARA K, Fujiyama T, Tokura Y, Honda T, et al
    Possible involvement of interleukin-22-producing CD103(+) CD8(+) T cells in the epidermal hyperplasia of atopic dermatitis.
    J Dermatol. 2022 Apr 1. doi: 10.1111/1346-8138.16382.
    PubMed    


  26. GAMBICHLER T, Abu Rached N, Scholl L, Behle B, et al
    Reproducible leukocytoclastic vasculitis following severe acute respiratory syndrome coronavirus 2 vaccination.
    J Dermatol. 2022;49:145-146.
    PubMed    


    March 2022
  27. KAN T, Tanaka A, Kanamoto M, Morioke S, et al
    Longitudinal prevalence of atopic dermatitis among freshmen at Hiroshima University between 2002 and 2019.
    J Dermatol. 2022 Mar 22. doi: 10.1111/1346-8138.16366.
    PubMed     Abstract available


  28. MAENO M, Tamagawa-Mineoka R, Arakawa Y, Masuda K, et al
    Facial discoid lupus erythematosus during dupilumab treatment for atopic dermatitis.
    J Dermatol. 2022 Mar 18. doi: 10.1111/1346-8138.16356.
    PubMed    


  29. HE W, Hu X, Hua H, Li K, et al
    Allergic contact stomatitis due to desensitizing toothpastes.
    J Dermatol. 2022 Mar 8. doi: 10.1111/1346-8138.16338.
    PubMed     Abstract available


  30. MATSUSHIMA Y, Mizutani K, Iida S, Ichishi M, et al
    Severe skin inflammation leads to salivary gland atrophy and dysfunction.
    J Dermatol. 2022 Mar 7. doi: 10.1111/1346-8138.16334.
    PubMed     Abstract available


  31. UCHIYAMA A, Fujiwara C, Inoue Y, Motegi SI, et al
    Real-world effectiveness and safety of baricitinib in Japanese patients with atopic dermatitis: A single-center retrospective study.
    J Dermatol. 2022 Mar 6. doi: 10.1111/1346-8138.16350.
    PubMed    


  32. LEE E, Lee S, Tashiro Y, Ogihara M, et al
    Sequential screening of biomarkers in a case of drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms occurring with virus reactivation and autoimmune disease.
    J Dermatol. 2022 Mar 3. doi: 10.1111/1346-8138.16341.
    PubMed    


  33. KOREKAWA A, Nakajima K, Fukushi K, Nakano H, et al
    Three cases of drug-induced hypersensitivity syndrome associated with mRNA-based coronavirus disease 2019 vaccines.
    J Dermatol. 2022 Mar 3. doi: 10.1111/1346-8138.16347.
    PubMed     Abstract available


  34. KONO T, Miyachi Y, Kawashima M
    Reply to Comment on "Clinical significance of the water retention and barrier function-improving capabilities of ceramide-containing formulations: A qualitative review".
    J Dermatol. 2022;49:e124.
    PubMed    


    February 2022
  35. OKUNE M, Okiyama N, Fukuzono M, Sasaki K, et al
    Development of systemic lupus erythematosus after dupilumab treatment in a case of atopic dermatitis.
    J Dermatol. 2022 Feb 27. doi: 10.1111/1346-8138.16322.
    PubMed     Abstract available


  36. NAKAZAWA S, Phadungsakswasdi P, Kageyama H, Fukuchi K, et al
    Decreased serum level of suprabasin in patients with nickel allergy.
    J Dermatol. 2022 Feb 17. doi: 10.1111/1346-8138.16315.
    PubMed    


  37. NISHIOKA K, Koizumi A, Takita Y
    Seven cases of contact dermatitis due to stearyl alcohol contained in topical medications.
    J Dermatol. 2022 Feb 16. doi: 10.1111/1346-8138.16325.
    PubMed     Abstract available


  38. HARADA K, Hagiwara T
    Gardner-Diamond syndrome complicated with chronic urticaria successfully treated with antihistamine.
    J Dermatol. 2022;49:e75-e76.
    PubMed    


    January 2022
  39. HATTORI N, Koike Y, Murota H
    Treatment with an interleukin-17 inhibitor resulted in complete remission of psoriasis and flare-up of atopic dermatitis.
    J Dermatol. 2022 Jan 17. doi: 10.1111/1346-8138.16308.
    PubMed    


  40. JEDLOWSKI PM, Jedlowski MF
    Coronavirus disease 2019-associated immunoglobulin A vasculitis/Henoch-Schonlein purpura: A case report and review.
    J Dermatol. 2022;49:190-196.
    PubMed     Abstract available


  41. JIN WJ, Ahn SW, Jang SH, Hong SM, et al
    Leukocytoclastic vasculitis after coronavirus disease 2019 vaccination.
    J Dermatol. 2022;49:e34-e35.
    PubMed    


  42. OHATA M, Oda Y, Washio K, Fukunaga A, et al
    Efficacy of additional treatment for chronic spontaneous urticaria refractory to treatment - A single-center retrospective real-world study.
    J Dermatol. 2022;49:e7-e8.
    PubMed    


    December 2021
  43. BABA A, Kanekura T, Tsubouchi H
    Lichenoid drug eruption after coronavirus disease 2019 vaccination.
    J Dermatol. 2021 Dec 27. doi: 10.1111/1346-8138.16294.
    PubMed    


  44. INAZAWA-TERADA M, Namiki T, Omigawa C, Fujimoto T, et al
    An epidemiological survey of anhidrotic/hypohidrotic ectodermal dysplasia in Japan: High prevalence of allergic diseases.
    J Dermatol. 2021 Dec 13. doi: 10.1111/1346-8138.16278.
    PubMed     Abstract available


  45. HIRANO Y, Kosumi H, Miyazawa H, Yanagi T, et al
    Toxic epidermal necrolysis induced by tirabrutinib.
    J Dermatol. 2021 Dec 5. doi: 10.1111/1346-8138.16274.
    PubMed    


  46. KONO T, Miyachi Y, Kawashima M
    Clinical significance of the water retention and barrier function-improving capabilities of ceramide-containing formulations: A qualitative review.
    J Dermatol. 2021;48:1807-1816.
    PubMed     Abstract available


  47. IWATA H, Kamiya K, Kado S, Nakaya T, et al
    Case of immunoglobulin A vasculitis following coronavirus disease 2019 vaccination.
    J Dermatol. 2021;48:e598-e599.
    PubMed    


    November 2021
  48. MIYAGAWA A, Adachi T, Kobayashi Y, Takamiyagi S, et al
    Plasmapheresis as a promising treatment option in apalutamide-associated toxic epidermal necrolysis.
    J Dermatol. 2021 Nov 26. doi: 10.1111/1346-8138.16248.
    PubMed    


  49. MATSUMOTO Y, Imamura S, Fukumoto A, Lee K, et al
    Case of oral mite anaphylaxis: Contamination of wheat flour by mites determined by enzyme-linked immunosorbent assay.
    J Dermatol. 2021 Nov 18. doi: 10.1111/1346-8138.16227.
    PubMed    


  50. NAKAMURA R, Tanaka A, Kinoshita H, Ishii K, et al
    Minocycline-induced anaphylaxis mediated by antigen-specific immunoglobulin E.
    J Dermatol. 2021 Nov 9. doi: 10.1111/1346-8138.16228.
    PubMed    


  51. HASHIZUME H, Ishikawa Y, Ajima S
    Is steroid pulse therapy a suitable treatment for drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms? A systematic review of case reports in patients treated with corticosteroids in Japan.
    J Dermatol. 2021 Nov 9. doi: 10.1111/1346-8138.16230.
    PubMed     Abstract available


  52. TOUBI E, Vadasz Z
    Predictive features associated with chronic spontaneous urticaria recurrence.
    J Dermatol. 2021;48:1786-1788.
    PubMed     Abstract available


  53. WU RW, Lin TK
    Oxford-AstraZeneca COVID-19 vaccine-induced acute localized exanthematous pustulosis.
    J Dermatol. 2021;48:e562-e563.
    PubMed    


  54. MAURELLI M, Bellinato F, Girolomoni G
    Adrenergic urticaria successfully treated with omalizumab.
    J Dermatol. 2021;48:e541-e542.
    PubMed    


  55. CHEN TL, Yip HT, Wang JH, Chang CH, et al
    Risk of chronic spontaneous urticaria in reproductive-aged women with abnormal uterine bleeding: A population-based cohort study.
    J Dermatol. 2021;48:1754-1762.
    PubMed     Abstract available


  56. OKU A, Nakai K, Ikenaga T, Sato K, et al
    Case of afatinib-induced severe purpuric drug eruption with gastrointestinal bleeding.
    J Dermatol. 2021;48:e534-e535.
    PubMed    


    October 2021
  57. MIURA S, Moriyama T, Yoshimura J, Umehara K, et al
    Anaphylaxis to lipid transfer protein from butterbur scape.
    J Dermatol. 2021 Oct 29. doi: 10.1111/1346-8138.16213.
    PubMed    


  58. SATO A, Takemori C, Fukumoto T, Aoyama N, et al
    Cutaneous leukocytoclastic vasculitis induced by thiamazole.
    J Dermatol. 2021 Oct 22. doi: 10.1111/1346-8138.16205.
    PubMed    


  59. GOTO T, Kogure A, Kuwano Y
    Drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms with skin eruptions mimicking acute generalized exanthematous pustulosis.
    J Dermatol. 2021 Oct 8. doi: 10.1111/1346-8138.16190.
    PubMed    


  60. KAGE P, Simon JC, Treudler R
    Case of atopic eczema treated with dupilumab throughout conception, pregnancy, and lactation.
    J Dermatol. 2021;48:E484-E485.
    PubMed    


  61. KURIYAMA Y, Shimizu A, Oka H, Sato M, et al
    Erythema nodosum-like eruption in coronavirus disease 2019: A case report and literature review of Asian countries.
    J Dermatol. 2021;48:1588-1592.
    PubMed     Abstract available


  62. LIU KL, Tsai TL, Tsai WC, Tsai SF, et al
    Prenatal heavy metal exposure, total immunoglobulin E, trajectory, and atopic diseases: A 15-year follow-up study of a Taiwanese birth cohort.
    J Dermatol. 2021;48:1542-1549.
    PubMed     Abstract available


    September 2021
  63. HUANG HL, Xu HM, Liu YD, Shou DW, et al
    Fecal microbiota transplantation as a novel approach for the treatment of atopic dermatitis.
    J Dermatol. 2021 Sep 27. doi: 10.1111/1346-8138.16169.
    PubMed    


  64. KIDO-NAKAHARA M, Yokote G, Yoshida M, Furue M, et al
    Atopic Dermatitis Control Tool (ADCT): A useful tool for self-evaluation in patients with atopic dermatitis.
    J Dermatol. 2021 Sep 27. doi: 10.1111/1346-8138.16176.
    PubMed    


  65. ADACHI M, Adachi T, Yokota M, Ichimura C, et al
    A case of vancomycin-induced linear IgA bullous dermatosis with toxic epidermal necrolysis-like symptoms: Palmoplantar eruptions as a possible risk marker.
    J Dermatol. 2021 Sep 24. doi: 10.1111/1346-8138.16173.
    PubMed    


    August 2021
  66. KAWANO N, Inoue H, Shiratori T
    Onset of Stevens-Johnson syndrome and toxic epidermal necrolysis overlap due to tirabrutinib.
    J Dermatol. 2021 Aug 4. doi: 10.1111/1346-8138.16093.
    PubMed    


Thank you for your interest in scientific medicine.


AMEDEO Hypersensitivity Reaction is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: